The nucleotide derivatives inosine and inosinic acid inhibit intestinal absorption of mizoribine in rats

European Journal of Pharmacology

Volumn 531, Issue 1-3, 2006, Pages 140-144

  Okada, Makoto ^a   Suzuki, Kimihiro ^a   Nakashima, Masahiro ^a   Nakanishi, Takashi ^a   Fujioka, Noriyasu ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b ASAHI KASEI PHARMA CORPORATION   (Japan)

Author keywords

Inosine; Inosinic acid; Intestinal absorption; Mizoribine; N1 transporter

Indexed keywords

INOSINE; INOSINE PHOSPHATE; MIZORIBINE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG URINE LEVEL; INTESTINE ABSORPTION; INTESTINE LOOP; MALE; NONHUMAN; PRIORITY JOURNAL; PYLORUS; RAT;

ANIMALS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; INOSINE; INOSINE MONOPHOSPHATE; INTESTINAL ABSORPTION; MALE; METABOLIC CLEARANCE RATE; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOSIDES;

EID: 32044460339     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.013     Document Type: Article

References (22)

1. Y. Abe, Y. Tsuji, M. Hisano, M. Nakada, K. Miura, S. Watanabe, Y. Odajima, and Y. Iikura Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis Pediatr. Int. 46 2004 597 600
2. D.W. Bates Improving the use of therapeutic drug monitoring Ther. Drug Monit. 20 1998 550 555
3. U. Ceglarek, J. Lembcke, G.M. Fiedler, M. Werner, H. Witzigmann, J.P. Hauss, and J. Thiery Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry Clin. Chim. Acta 346 2004 181 190
4. D.K. Cho, J.H. Kim, S.H. Park, J.C. Kim, C.D. Kim, M.Y. Baek, S.J. Kim, S.H. Kim, T.H. Kwon, Y.L. Kim, Y.W. Kim, and S.K. Chang The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial) Transplant. Proc. 33 2001 3256 3258
5. C.J. Destache Use of therapeutic drug monitoring in pharmacoeconomics Ther. Drug Monit. 15 1993 608 610
6. P.W. Hager, F.R. Collart, E. Huberman, and B.S. Mitchell Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding Biochem. Pharmacol. 49 1995 1323 1329
7. H. Hosotsubo, S. Takahara, and N. Taenaka Simplified high-performance liquid chromatographic method for determination of mizoribine in human serum J. Chromatogr. 432 1988 340 345
8. J.F. Hruska, J.M. Bernstein, R.G. Douglas Jr., and C.B. Hall Effects of ribavirin on respiratory syncytial virus in vitro Antimicrob. Agents Chemother. 17 1980 770 775
9. K. Kamata, M. Okubo, E. Ishigamori, Y. Masaki, H. Uchida, K. Watanabe, and N. Kashiwagi Immunosuppressive effect of bredinin on cell-mediated and humoral immune reactions in experimental animals Transplantation 35 1983 144 149
10. F. Kawana, S. Shigeta, and E. De Clercq Inhibitory effects of several antiviral compounds on the replication of respiratory syncytial virus in vitro Antivir. Res., Suppl. 1 1985 83 88
11. T. Kusumi, M. Tsuda, T. Katsunuma, and M. Yamamura Dual inhibitory effect of bredinin Cell Biochem. Funct. 7 1989 201 204
12. A. Lindholm, and J. Sawe Pharmacokinetics and therapeutic drug monitoring of immunosuppressants Ther. Drug Monit. 17 1995 570 573
13. Y. Matsuki, K. Suzuki, M. Kawakami, Y. Kawaguchi, T. Ishizuka, and H. Nakamura Nephrotic syndrome based on diffuse proliferative lupus nephritis that responded to mizoribine in combination with corticosteroid: a case report J. Natl. Def. Med. Coll. 19 1994 38 42
14. K. Mizuno, M. Tsujino, M. Takada, M. Hayashi, and K. Atsumi Studies on bredinin. I. Isolation, characterization and biological properties J. Antibiot. (Tokyo) 27 1974 775 782
15. J. Murase, K. Mizuno, K. Kawai, S. Nishiumi, Y. Kobayashi, M. Hayashi, T. Morino, T. Suzuki, and S. Baba Absorption, distribution, metabolism and excretion of bredinin in rats Oyoyakuri 15 1978 829 835
16. S.D. Patil, and J.D. Unadkat Sodium-dependent nucleoside transport in the human intestinal brush-border membrane Am. J. Physiol. 272 1997 G1314 G1320
17. S.D. Patil, L.Y. Ngo, P. Glue, and J.D. Unadkat Intestinal absorption of ribavirin is preferentially mediated by the Na+-nucleoside purine (N1) transporter Pharm. Res. 15 1998 950 952
18. D.R. Primmett, M. Levine, J.M. Kovarik, E.A. Mueller, and P.A. Keown Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure Ther. Drug Monit. 20 1998 276 283
19. T. Shibasaki, A. Koyama, A. Hishida, E. Muso, G. Osawa, H. Yamabe, H. Shiiki, H. Makino, H. Sato, I. Ishikawa, K. Maeda, K. Tomita, M. Arakawa, M. Ishida, M. Sato, M. Nagase, N. Kashihara, N. Yorioka, T. Koike, T. Saito, T. Harada, T. Mitarai, T. Sugisaki, T. Nagasawa, Y. Tomino, Y. Nojima, Y. Kobayashi, and O. Sakai A randomized open-label comparative study of conventional therapy versus mizoribine only therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey) Clin. Exp. Nephrol. 8 2004 117 126
20. Y. Takahashi The 14-3-3 proteins: gene, gene expression, and function Neurochem. Res. 28 2003 1265 1273
21. S. Takei Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis Pediatr. Int. 44 2002 205 209
22. P.J. Taylor Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry Ther. Drug Monit. 26 2004 215 219